Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation

2014 ◽  
Vol 28 (12) ◽  
pp. 1393-1401 ◽  
Author(s):  
Silvia Lopez-Fernandez ◽  
Nicolas Manito-Lorite ◽  
Joan Antoni Gómez-Hospital ◽  
Josep Roca ◽  
Carles Fontanillas ◽  
...  
Keyword(s):  
Endothelial Dysfunction ◽  
Cardiogenic Shock ◽  
Heart Transplantation ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Allograft Vasculopathy ◽  
Coronary Endothelial Dysfunction

scholarly journals HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS

2016 ◽  
Vol 18 (2) ◽  
pp. 171-176
Author(s):  
A. О. Shevchenko
Keyword(s):  
Acute Rejection ◽  
Heart Transplantation ◽  
Statin Therapy ◽  
Standard Therapy ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Allograft Vasculopathy ◽  
Hypolipidemic Action ◽  
Long Term Prognosis

Statins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties. Statin therapy initiated early after heart transplantation improves the shortand long-term prognosis and outcomes, leading to a reduction in the incidence of cardiac allograft vasculopathy, acute rejection, and cancer. 

scholarly journals BENEFIT OF TACROLIMUS/MYCOPHENOLATE TO REDUCE CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION

2013 ◽  
Vol 61 (10) ◽  
pp. E798 ◽  
Author(s):  
Alistair Aaronson ◽  
Michelle Kittleson ◽  
Jignesh Patel ◽  
Matthew Rafiei ◽  
Ashley Osborne ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Allograft Vasculopathy
Sign in / Sign up

Export Citation Format

Share Document